Pharmafile Logo
Pharmafocus logo
Advanced Search

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018
Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …

News
dialogo

DIA – CMC Workshop

May 11, 2018
Medical Communications dia

This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from …

News
andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …

Appointment
lilly2_web

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018
Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

News
cancer-vs-alzheimer-1080x810

NanoBots: The science of small to dwarf the disease

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …

Feature
320px-human_embryonic_stem_cells_only_a

FDA launches lawsuits against stem cell clinics after patients rendered blind

May 10, 2018
Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma

At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …

News
soil-3301161_960_720

Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018
Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …

News

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

News
pharmafile_srping_2018_cover

The new and improved Spring 2018 edition of Pharmafile is available to read online now!

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

News
joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

Appointment

GSK’s CFO chooses to exit company

May 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …

News
valeant_web

Valeant seeks clean slate with rebrand, new company name

May 9, 2018
Medical Communications, Research and Development Valeant, pharma

In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant …

News
bald_man

Old osteoporosis drug could be used to treat hair loss

May 9, 2018
Research and Development biotech, drugs, hair loss, pharma, pharmaceutical

Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the …

News
faron_share

Faron’s stock freefalls by 80% after key drug failure

May 9, 2018
Research and Development ARDS, Faron, acute respiratory distress syndrome, pharma, traumakine

Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its recombinant human interferon …

News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

News
credit_-_daniel_leal-olivas-afp

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …

News
eye

All eyes on dry eye disease

May 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing TopiVert, dry eye disease, eye, pharma

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …

Feature
novartis_side_building

FDA approves Novartis combo in rare thyroid cancer subtype

May 8, 2018
Manufacturing and Production, Sales and Marketing Cancer, FDA, Tafinlar, mekinist, thyroid cancer

The FDA has announced its decision to approve the use of Novartis’ combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in …

News
jj

J&J’s ketamine-based antidepressant showed mixed success at Phase 3

May 8, 2018
Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Ketamine, antidepressant, depression, esketamine, pharma

Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled …

News

Genmab and Janssen’s Darzalex combo scores FDA approval in multiple myeloma

May 8, 2018
Manufacturing and Production, Sales and Marketing FDA, Genmab, Janssen, US, darzalex, multiple myeloma, pharma

Genmab and Janssen have revealed that their combination of Darzalex (daratumumab) with bortezomib (Velcade), melphalan, and prednisone (VMP) has received …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026